Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

被引:32
|
作者
Schilder, C. M. T. [1 ]
Seynaeve, C. [2 ]
Linn, S. C. [3 ]
Boogerd, W. [4 ,5 ]
Beex, L. V. A. M. [6 ]
Gundy, C. M. [1 ]
Nortier, J. W. R. [7 ]
van de Velde, C. J. H. [8 ]
van Dam, F. S. A. M. [1 ]
Schagen, S. B. [1 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands
[2] Dr Daniel Den Hoed Canc Ctr, Dept Med Oncol, Erasmus Med Ctr, NL-3008 AE Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Neurooncol, Amsterdam, Netherlands
[5] Slotervaart Med Ctr, Dept Neurol, Amsterdam, Netherlands
[6] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands
[7] Leiden Univ, Med Ctr, Dept Clin Oncol, Leiden, Netherlands
[8] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands
关键词
Breast cancer; Postmenopausal; Cognitive function; Neuropsychological testing; Psychological function; Adjuvant systemic treatment; REPRODUCTIVE PERIOD; CHEMOTHERAPY; RISK; IMPAIRMENT; WOMEN; DYSFUNCTION; DEMENTIA; PEOPLE;
D O I
10.1016/j.critrevonc.2009.11.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This study aimed to identify medical and psychological predictors for cognitive performance of breast cancer (BC) patients before the start of adjuvant systemic treatment and to compare cognitive performance between BC patients and healthy controls adjusting for medical and psychological variables. Material: 205 postmenopausal BC patients underwent pre-treatment neuropsychological tests and provided medical and psychological data. 124 healthy controls underwent the same assessment. Results: 'Treatment for diabetes mellitus' and/or 'hypertension', 'less hours spent on cognitively stimulating activities', 'fewer days since surgery' and 'more reproductive years' were associated with worse cognitive performance in the BC patients, independent of age and IQ. Cognitive differences between BC patients and healthy controls could partly be explained by the evaluated variables. Conclusion: The results stress the need for adjustment for pre-treatment cognitive differences between study groups, and also indicate that further research into pre-treatment cognitive dysfunction is warranted. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 141
页数:9
相关论文
共 50 条
  • [21] Biological and psychological predictors of cognitive function in breast cancer patients before surgery
    Aspelund, Snaefridur Gudmundsdottir
    Halldorsdottir, Thorhildur
    Agustsson, Gudjon
    Tobin, Hannah Ros Sigurdardottir
    Wu, Lisa M.
    Amidi, Ali
    Johannsdottir, Kamilla R.
    Lutgendorf, Susan K.
    Telles, Rachel
    Daly, Huldis Franksdottir
    Sigurdardottir, Kristin
    Heiddis B., Valdimarsdottir
    Baldursdottir, Birna
    SUPPORTIVE CARE IN CANCER, 2024, 32 (01)
  • [22] Association between depression and anxiety status of breast cancer patients before adjuvant chemotherapy and chemotherapy-induced adverse events
    Lv, Dan
    Lan, Bo
    Zhang, Li
    Sun, Xiaoying
    Yang, Min
    Ma, Fei
    CANCER MEDICINE, 2023, 12 (04): : 4794 - 4800
  • [23] Cognitive Impairment in Older Patients With Breast Cancer Before Systemic Therapy: Is There an Interaction Between Cancer and Comorbidity?
    Mandelblatt, Jeanne S.
    Stern, Robert A.
    Luta, Gheorghe
    McGuckin, Meghan
    Clapp, Jonathan D.
    Hurria, Arti
    Jacobsen, Paul B.
    Faul, Leigh Anne
    Isaacs, Claudine
    Denduluri, Neelima
    Gavett, Brandon
    Traina, Tiffany A.
    Johnson, Patricia
    Silliman, Rebecca A.
    Turner, R. Scott
    Howard, Darlene
    Van Meter, John W.
    Saykin, Andrew
    Ahles, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (18) : 1909 - +
  • [24] Psychological resilience and post-traumatic stress disorder as chain mediators between personality traits and cognitive functioning in patients with breast cancer
    Zhang, Xinmiao
    Lu, Junyue
    Ding, Zhangyi
    Zhong, Gaoxiang
    Qiao, Yan
    Li, XiChen
    Cui, Huixia
    BMC PSYCHIATRY, 2024, 24 (01)
  • [25] Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor-positive breast cancer patients: upfront or sequential?
    Dediu, M.
    Median, D.
    Alexandru, A.
    Vremes, G.
    Gal, C.
    Gongu, M.
    JOURNAL OF BUON, 2009, 14 (03): : 375 - 379
  • [26] Hippocampal functional connectivity is related to self-reported cognitive concerns in breast cancer patients undergoing adjuvant therapy
    Apple, Alexandra C.
    Schroeder, Matthew P.
    Ryals, Anthony J.
    Wagner, Lynne I.
    Cella, David
    Shih, Pei-An
    Reilly, James
    Penedo, Frank J.
    Voss, Joel L.
    Wang, Lei
    NEUROIMAGE-CLINICAL, 2018, 20 : 110 - 118
  • [27] Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
    Marzio E.E. Sabbioni
    Hans Peter Siegrist
    Marisa Bacchi
    Jürg Bernhard
    Monica Castiglione
    Beat Thürlimann
    Hervé Bonnefoi
    Lucien Perey
    Richard Herrmann
    Aron Goldhirsch
    Christoph Hürny
    Breast Cancer Research and Treatment, 2000, 59 : 279 - 287
  • [28] Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment
    Sabbioni, MEE
    Siegrist, HP
    Bacchi, M
    Bernhard, J
    Castiglione, M
    Thürlimann, B
    Bonnefoi, H
    Perey, L
    Herrmann, R
    Goldhirsch, A
    Hürny, C
    BREAST CANCER RESEARCH AND TREATMENT, 2000, 59 (03) : 279 - 287
  • [29] Adjuvant endocrine therapy side-effects among postmenopausal breast cancer patients in Malaysia
    Choo S.B.
    Saifulbahri A.
    Zullkifli S.N.
    Fadzil M.L.
    Redzuan A.M.
    Abdullah N.
    Bustamam R.S.A.
    Ahmad H.Z.
    Shah N.M.
    Climacteric, 2019, 22 (02): : 175 - 181
  • [30] Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
    Phillips, Kelly-Anne
    Aldridge, Julie
    Ribi, Karin
    Sun, Zhuoxin
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 126 (01) : 221 - 226